Pirin inhibits cellular senescence in melanocytic cells

American Journal of Pathology

Volumn 178, Issue 5, 2011, Pages 2397-2406

  Licciulli, Silvia ^a,e   Luise, Chiara ^b   Scafetta, Gaia ^a   Capra, Maria ^a   Giardina, Giuseppina ^a   Nuciforo, Paolo ^a,f   Bosari, Silvano ^c,d   Viale, Giuseppe ^a   Mazzarol, Giovanni ^a   Tonelli, Chiara ^c   Lanfrancone, Luisa ^a   Alcalay, Myriam ^a,c  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b European Institute of Oncology ^*  (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e WISTAR INSTITUTE   (United States)

^f NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; PIRIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL AGING; CELL POPULATION; CELL SENESCENCE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOCYTE; MELANOMA; NEVUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE;

EID: 79959278698     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.01.019     Document Type: Article

References (31)

1. Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585-621
2. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602 (Pubitemid 27152402)
3. Bennett DC: Human melanocyte senescence and melanoma susceptibility genes. Oncogene 2003, 22:3063-3069
4. Ben-Porath I, Weinberg RA: The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005, 37:961-976 (Pubitemid 40311739)
5. Wynford-Thomas D: Cellular senescence and cancer. J Pathol 1999, 187:100-111
6. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguria A, Zaballos A, Flores JM, Barbacid M, Beach D, Serrano M: Tumour biology: senescence in premalignant tumours. Nature 2005, 436:642 (Pubitemid 41117258)
7. Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA, Marais R, Wynford-Thomas D, Bennett DC: Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 2006, 95:496-505 (Pubitemid 44232559)
8. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS: BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005, 436:720-724 (Pubitemid 41117276)
9. Ha L, Merlino G, Sviderskaya EV: Melanomagenesis: overcoming the barrier of melanocyte senescence. Cell Cycle 2008, 7:1944-1948 (Pubitemid 352030338)
10. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A: Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 2001, 413:83-86 (Pubitemid 32843492)
11. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS: High frequency of BRAF mutations in nevi. Nat Genet 2003, 33:19-20 (Pubitemid 36068675)
12. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al: Mutations of the BRAF gene in human cancer. Nature 2002, 417: 949-954 (Pubitemid 34716871)
13. Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V, Larue L, Pritchard C, Marais R: Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 2009, 15:294-303
14. Pang H, Bartlam M, Zeng Q, Miyatake H, Hisano T, Miki K, Wong LL, Gao GF, Rao Z: Crystal structure of human pirin: an iron-binding nuclear protein and transcription cofactor. J Biol Chem 2004, 279: 1491-1498 (Pubitemid 38082678)
15. Wendler WM, Kremmer E, Forster R, Winnacker EL: Identification of pirin, a novel highly conserved nuclear protein. J Biol Chem 1997, 272:8482-8489 (Pubitemid 27147811)
16. Miyazaki I, Simizu S, Okumura H, Takagi S, Osada H: A small-molecule inhibitor shows that pirin regulates migration of melanoma cells. Nat Chem Biol 6:667-673
17. Adams M, Jia Z: Structural and biochemical analysis reveal pirins to possess quercetinase activity. J Biol Chem 2005, 280:28675-28682 (Pubitemid 41105768)
18. Gelbman BD, Heguy A, O'Connor TP, Zabner J, Crystal RG: Upregulation of pirin expression by chronic cigarette smoking is associated with bronchial epithelial cell apoptosis. Respir Res 2007, 8:10
19. Orzaez D, de Jong AJ, Woltering EJ: A tomato homologue of the human protein PIRIN is induced during programmed cell death. Plant Mol Biol 2001, 46:459-468 (Pubitemid 32665070)
20. Capra M, Nuciforo PG, Confalonieri S, Quarto M, Bianchi M, Nebuloni M, Boldorini R, Pallotti F, Viale G, Gishizky ML, Draetta GF, Di Fiore PP: Frequent alterations in the expression of serine/threonine kinases in human cancers. Cancer Res 2006, 66:8147-8154 (Pubitemid 44299182)
21. Smalley KS, Brafford P, Haass NK, Brandner JM, Brown E, Herlyn M: Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am J Pathol 2005, 166:1541-1554 (Pubitemid 40586522)
22. Fagiani E, Giardina G, Luzi L, Cesaroni M, Quarto M, Capra M, Germano G, Bono M, Capillo M, Pelicci P, Lanfrancone L: RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas. Cancer Res 2007, 67:3064-3073 (Pubitemid 46724843)
23. Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, Van Parijs L, Jaenisch R, Jacks T: Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci USA 2004, 101:10380-10385 (Pubitemid 38924934)
24. Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Lanfrancone L, Peschle C, Nolan GP, Pelicci PG: High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res 1998, 58:14-19 (Pubitemid 28027708)
25. Breslow A: Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg 1975, 182:572-575
26. Clark WH Jr: Human cutaneous malignant melanoma as a model for cancer. Cancer Metastasis Rev 1991, 10:83-88
27. Licciulli S, Luise C, Zanardi A, Giorgetti L, Viale G, Lanfrancone L, Carbone R, Alcalay M: Pirin delocalization in melanoma progression identified by high content immuno-detection based approaches. BMC Cell Biol 2010, 11:5
28. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M: Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 1997, 17:5598-5611 (Pubitemid 27357656)
29. Agger K, Cloos PA, Rudkjaer L, Williams K, Andersen G, Christensen J, Helin K: The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev 2009, 23:1171-1176
30. Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, Sedivy J, Hendrickson EA, Balan KV, Pantazis P, Wyche JH: Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 2002, 277:17154-17160 (Pubitemid 34967748)
31. Licciulli S, Cambiaghi V, Scafetta G, Gruszka AM, Alcalay M: Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation. Leukemia 2010, 24:429-437